Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as kinase inhibitor and uses thereof

Heterocyclic compounds as kinase inhibitor and uses thereof

US Patent 12428395 · Granted Sep 30, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted nanoparticle for the treatment of traumatic brain injury and other CNS 2025
Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses t2025
Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses t2025
Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses t2025
Ectonucleotide pyrophosphatase-phosphodiesterase-1 (ENPP1) inhibitors and uses t2025
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2025
Dopamine D3 receptor selective antagonists/partial agonists; method of making; a2024
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof2024
PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherap2023
Inhibitors of fibroblast activation protein2023
Compounds and methods of use2023
Inhibitors of fibroblast activation protein2022